Bevacizumab, olaparib and durvalumab in patients with relapsed ovarian cancer (the gineco bold study): prognostic value of kelim-b and nanostring? tumor inflammation signature
ANTICANCER RESEARCH（2023）
关键词
Ovarian carcinoma, poly (ADP-ribose) polymerase inhibitor, immunotherapy, bevacizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要